FDA Works with Partners to Establish Important Therapeutic Area Data Standards
October 25, 2012
Clarification, November 5, 2012: CFAST is a joint initiative of CDISC and the Critical Path Institute. The FDA and TransCelerate Biopharma, Inc. are partnering with CFAST in its Therapeutic Area Standards Program.
Thank you for helping us expand participation in this important work! We rely on people with lived experience of ALS to help ensure research reflects the needs and priorities of the community. Please use the form below to nominate someone whose experiences, perspectives, and interests may make them a strong contributor to an ALS Research Working Group. No scientific or medical background is required.
